U.S. Health Secretary Robert F. Kennedy Jr. pressured former CDC Director Susan Monarez to approve changes to the childhood vaccination schedule without reviewing scientific evidence, Monarez told a Senate panel Wednesday. She said Kennedy insisted she commit to pre-approving recommendations from the CDC’s vaccine advisory board and fire staff overseeing vaccine policy. Monarez refused, and days later, President Donald Trump dismissed her after just 29 days in the role.
Monarez, a microbiologist and immunologist with nearly two decades of federal service, was the first CDC director confirmed by the Senate. She testified that Kennedy told her “there was no science” supporting the current vaccine schedule and that if she did not comply, she should resign. He also barred her from speaking with Senators. Kennedy, however, denied demanding pre-approval during a Senate Finance Committee hearing earlier this month.
Her ousting triggered the resignation of four senior CDC officials, who cited Kennedy’s anti-vaccine stance and misinformation. Critics, including medical professionals, have called for Kennedy to step down, warning his policies undermine public health. Senator Bill Cassidy, chair of the Senate health committee, said the firing raised questions about why someone with “unimpeachable scientific credentials” was pushed out so quickly.
Kennedy has reshaped the CDC’s vaccine advisory board, replacing all 17 members with 12 new appointees. Experts warn that upcoming votes on childhood vaccines lack the usual scientific rigor, since key work group meetings have not been held. Cassidy cautioned Americans against trusting potential changes to the vaccine schedule. Kennedy has already narrowed eligibility for COVID-19 shots and cut funding for mRNA vaccine research, deepening concerns over U.S. vaccination policy.


U.S. Sanctions Tanzanian Police Official Over Human Rights Violations
The four types of dementia most people don’t know exist
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access
Why the future of marijuana legalization remains hazy despite high public support
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
Trump Administration to Reduce NATO Military Commitments in Europe
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
U.S. Sanctions Iran’s Strait of Hormuz Authority as Global Oil Markets Face Turmoil
U.S. Reinstates Sanctions on U.N. Expert Francesca Albanese Amid Legal Battle
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
TrumpRx Expands Discount Drug Access With 600 Generic Medications
CDC Expands Ebola Screening Efforts at U.S. Entry Points Amid Congo and Uganda Outbreak
DOJ Opens Criminal Investigation Into E. Jean Carroll Over Alleged Perjury
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
US Imposes Fresh Iran Oil Sanctions Despite Progress on Ceasefire Talks
Netanyahu Orders Expansion of Israeli Control in Gaza to 70% 



